Kuwait · Delayed Price · Currency is KWD · Price in KWF KWSE:NIH Statistics
Total Valuation
KWSE:NIH has a market cap or net worth of KWD 29.48 million. The enterprise value is 29.93 million.
| Market Cap | 29.48M |
| Enterprise Value | 29.93M |
Important Dates
The last earnings date was Tuesday, March 31, 2026.
| Earnings Date | Mar 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KWSE:NIH has 245.64 million shares outstanding. The number of shares has increased by 1.03% in one year.
| Current Share Class | 245.64M |
| Shares Outstanding | 245.64M |
| Shares Change (YoY) | +1.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.55% |
| Owned by Institutions (%) | n/a |
| Float | 154.24M |
Valuation Ratios
The trailing PE ratio is 15.47.
| PE Ratio | 15.47 |
| Forward PE | n/a |
| PS Ratio | 4.48 |
| PB Ratio | 0.60 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | 15.84 |
| P/OCF Ratio | 15.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.31, with an EV/FCF ratio of 16.08.
| EV / Earnings | 15.71 |
| EV / Sales | 4.55 |
| EV / EBITDA | 15.31 |
| EV / EBIT | 16.45 |
| EV / FCF | 16.08 |
Financial Position
The company has a current ratio of 4.95, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.95 |
| Quick Ratio | 4.62 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 1.19 |
| Interest Coverage | 8.12 |
Financial Efficiency
Return on equity (ROE) is 3.90% and return on invested capital (ROIC) is 4.06%.
| Return on Equity (ROE) | 3.90% |
| Return on Assets (ROA) | 2.03% |
| Return on Invested Capital (ROIC) | 4.06% |
| Return on Capital Employed (ROCE) | 3.38% |
| Weighted Average Cost of Capital (WACC) | 4.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 4.11 |
Taxes
In the past 12 months, KWSE:NIH has paid 6,343 in taxes.
| Income Tax | 6,343 |
| Effective Tax Rate | 0.33% |
Stock Price Statistics
The stock price has decreased by -21.00% in the last 52 weeks. The beta is -0.10, so KWSE:NIH's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -21.00% |
| 50-Day Moving Average | 0.11 |
| 200-Day Moving Average | 0.14 |
| Relative Strength Index (RSI) | 64.66 |
| Average Volume (20 Days) | 562,224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KWSE:NIH had revenue of KWD 6.58 million and earned 1.91 million in profits. Earnings per share was 0.01.
| Revenue | 6.58M |
| Gross Profit | 3.65M |
| Operating Income | 1.82M |
| Pretax Income | 1.90M |
| Net Income | 1.91M |
| EBITDA | 1.95M |
| EBIT | 1.82M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 7.23 million in cash and 2.21 million in debt, with a net cash position of 5.02 million or 0.02 per share.
| Cash & Cash Equivalents | 7.23M |
| Total Debt | 2.21M |
| Net Cash | 5.02M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 49.51M |
| Book Value Per Share | 0.18 |
| Working Capital | 7.70M |
Cash Flow
In the last 12 months, operating cash flow was 1.87 million and capital expenditures -12,597, giving a free cash flow of 1.86 million.
| Operating Cash Flow | 1.87M |
| Capital Expenditures | -12,597 |
| Depreciation & Amortization | 135,322 |
| Net Borrowing | -234,104 |
| Free Cash Flow | 1.86M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 55.45%, with operating and profit margins of 27.64% and 28.95%.
| Gross Margin | 55.45% |
| Operating Margin | 27.64% |
| Pretax Margin | 28.79% |
| Profit Margin | 28.95% |
| EBITDA Margin | 29.69% |
| EBIT Margin | 27.64% |
| FCF Margin | 28.28% |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 1.67%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 1.67% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.01% |
| Buyback Yield | -1.03% |
| Shareholder Yield | 0.64% |
| Earnings Yield | 6.46% |
| FCF Yield | 6.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 5, 2025. It was a forward split with a ratio of 1.06.
| Last Split Date | Aug 5, 2025 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
KWSE:NIH has an Altman Z-Score of 4.23 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.23 |
| Piotroski F-Score | 5 |